·
4 MIN READ

Will the U.S. get its first supervised drug consumption site?

As a federal appeals court weighs the question, the AMA details the evidence showing such facilities can save lives and improve public health.

Overdose Epidemic
·
4 MIN READ

As COVID-19 surges, AMA sounds alarm on nation’s overdose epidemic

Learn about the policy steps that must be taken to improve access to lifesaving substance-use disorder treatment.

Overdose Epidemic
·
9 MIN READ

Dec. 11, 2020: National Advocacy Update 

What you need to know: 2021 Medicare Physician Payment Final Rule and more in the latest National Advocacy Update.

Advocacy Update
Woman in a suit standing in a dark room under a shaft of light.
·
4 MIN READ

How to dismantle stigmas surrounding mental health conditions

A big part of improving access to behavioral health care is for physicians to help tackle the shame and blame that sometimes surrounds such care.

Public Health
·
9 MIN READ

Dec. 4, 2020: National Advocacy Update 

Administration finalizes drug pricing actions and more in the latest National Advocacy Update.

Advocacy Update
·
3 MIN READ

Nov. 20, 2020: Advocacy Update spotlight on Highlights from the November 2020 AMA Special Meeting

Highlights from the November 2020 AMA Special Meeting in the latest Advocacy Update spotlight.

Advocacy Update
Bottle of pills in foregroud with background of more bottles in shadow
·
3 MIN READ

AMA to push for better access to opioid-use disorder treatments

The AMA will advocate sustained funding for evidence-based care and support research to help bring more treatments into the primary care setting.

Overdose Epidemic
·
4 MIN READ

AMA announces policies adopted on final day of Special Meeting

Policies adopted include improving access to substance use disorder treatment, protection for residents and fellows.

Press Releases
Scale in medical office
·
3 MIN READ

COVID-19 exacerbates drug shortages. AMA details next steps.

Analgesics, sedatives among drugs affected by the pandemic. Delegates urge improvements to the global pharmaceutical product supply chain.

Public Health